Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 804 results for "cvm"

BRF: Material Fact
TheStreet.com

Material Fact - Conclusion of the sale of the dairy division -...

BRF S.A. A Public Held Company CNPJ 01.838.723/0001-27 NIRE 42.300.034.240 CVM 16269-2 BRF S.A. ("BRF" or "Company" - Bovespa: BRFS3; NYSE: BRFS), pursuant to CVM Instruction 358 of January 3, 2002, as amended, following the Material Fact of ... Noodls, 1 month ago
BRF: Material Fact Sys-Con Italia, 1 month ago
[x]  

Relatively Low Return on Equity Detected in Shares of StemCells in the Biotechnology Industry (STEM, PARD, CVM, BTX, IMMU)

(Comtex SmarTrend(R)) Below are the three companies in the Biotechnology industry with the lowest return on equity. The ROE is a general indication of the company's efficiency; investors usually look for companies with ROEs that are high and
 Individual.com1 month ago Lowest Return on Equity in the Biotechnology Industry Detected in Shares of StemCells (STEM, GTXI, PARD, CVM, BTX)  Individual.com2 months ago

HIV/HPV Guru Comes On Board To Battle Cancer, Driving CEL-SCI's Market Opportunity

Jul. 27, 2015 12:46 PM ET | About: Cel-Sci Corporation (CVM), Includes: ABT, BDX, BLUE, GSK, KITE, MRK, RHHBY by: Sharon di Stefano Summary CEL-SCI takes a big jump forward with new clinical sites within the UCSF under the lead of a ...
 Seeking Alpha1 month ago CEL-SCI Corporation : HIV/HPV Guru Comes on Board to Battle Cancer, Driving CEL-SCI's Multi-billion Dollar Market Opportunity  4 Traders1 month ago
[x]  

Traders Get Bullish on Shares of CEL-SCI, Shares Up 7.9% (CVM)

CEL-SCI (AMEX:CVM) is one of today's best performing penny stocks, up 7.9% to $0.64 on 1.2x average daily volume. Thus far today, CEL-SCI has traded 916,000 shares, vs. average volume of 739,000 shares per day. The stock has outperformed the Dow ...
 Individual.com2 months ago CEL-SCI Up 7.9%, Penny Stock Attracts Attention (CVM)  Individual.com2 months ago

Stock to Watch: CEL-SCI Down 7.7% (CVM)

CEL-SCI (AMEX:CVM) is one of today's worst performing penny stocks, down 7.7% to $0.61 on 2.5x average daily volume. CEL-SCI has traded 1.6 million shares thus far today, vs. average volume of 657,000 shares per day. The stock has underperformed ...
 Individual.com2 months ago Hot Stock: CEL-SCI, Shares Drop 7.7% (CVM)  Individual.com2 months ago
Forex Magnates

Oi CEO settles with Brazil market regulator

The CEO of Brazilian operator Oi, Bayard Gontijo, struck a deal with the Brazilian Securities Commission (CVM) to end an administrative proceeding in which he is accused of failing to file a document submitted to the Securities and Exchange ...
 Telecompaper1 month ago Brazilian Watchdog Warns IronFX Is Unauthorized to Operate in the Country  Forex Magnates1 week ago

Top 5 Companies in the Biotechnology Industry With the Lowest Beta (IMMU, NSPH, OXGN, DSCO, CVM)

Written on Sun, 08/02/2015 - 10:45am By Amy Schwartz Below are the three companies in the Biotechnology industry with the lowest betas. Lower-beta stocks mean minimal volatility and are therefore generally considered to be a less risk and ...
 Comtex SmarTrend4 weeks ago Poniard Pharmaceuticals is Among the Companies in the Biotechnology Industry With the Lowest Beta (PARD, OXGN, CYTR, CVM, PIP)  Individual.com1 month ago

S-3 - CEL SCI CORP (0000725363) (Filer)

Document Format Files Seq Description Document Type Size 1 REGISTRATION STATEMENT cvm_s3.htm S-3 560293 2 OPINION cvm_ex5.htm EX-5 9088 3 CONSENT cvm_ex231.htm EX-23.1 3790 4 CONSENT cvm_ex232.htm EX-23.2 3852 Complete submission text file ...
 SEC1 month ago
TeleTrader.com

Cel-Sci beats by $0.05, beats on revenue

8/7/2015, 10:36 PM (Source: Seeking Alpha) Cel-Sci (NYSEMKT:CVM): FQ3 EPS of -$0.06 beats by $0.05 . Revenue of $0.39M (+3800.0% Y/Y) beats by $0.29M .
 TeleTrader.com3 weeks ago CEL-SCI Reports Record Monthly Patient Enrollment in July for Its Phase 3 Head and Neck Cancer Trial  Wallstreet Online3 weeks ago CEL-SCI (CVM) Reports Record Monthly Patient Enrollment In July For Its Phase III Head And Neck Cancer Trial 8/3/2015  ClinicSpace3 weeks ago CEL SCI : Reports Record Monthly Patient Enrollment in July for Its Phase 3 Head and Neck Cancer Trial  4 Traders3 weeks ago
[x]  

GMED Expands Product Portfolio, CVM On Track, TCON To Get $3 Mln, REPH On Watch

(RTTNews.com) - CEL-SCI Corp.'s ( CVM ) ongoing phase III trial of its investigational immunotherapy Multikine in just diagnosed, not yet treated patients with head and neck cancer enrolled 25 patients last month. The total patient enrollment is ...
 Nasdaq1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cvm
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less